LET
IFODRONE NEWCONNECT LISTED

Contracts

All Active Completed

source: current reports (ESPI/EBI) · incomplete data — not every contract is disclosed · 8 contracts in the database

DISCLOSED VALUE 12M
—
no contracts with a disclosed value
SHARE OF REVENUE 12M
—
no revenue data in the database
LARGEST COUNTERPARTY
—
no data
LONGEST TERM
3 years
until 2029
Ended

Intelldrones S.R.L. (Rumunia)

undisclosed

Nowa · List intencyjny ws. komercjalizacji technologii IFODRONE na rynku rumuńskim (nabycie demonstratora + umowa wyłącznego przedstawicielstwa) · until 2026

List intencyjny ws. komercjalizacji technologii IFODRONE na rynku rumuńskim (nabycie demonstratora + umowa wyłącznego przedstawicielstwa)

Status

Ended

Signing date

April 29, 2026

Term

—

Report Q1 2026

SHOWING 1–1 OF 1

Portfolio summary

Contracts
8
Active
7
Total value
—
Average value
—
Since
March 17, 2025

Where this data comes from

Contracts come from current reports (ESPI/EBI) — the company discloses only those exceeding its materiality threshold. The list is by definition incomplete.

Status — inferred from the event type and the term's end date, not a dedicated source field.

Share of revenue 12M — only when both the contracts' dominant currency and the company's reporting currency are PLN, with no currency conversion.

≥ 50% — a new PLN contract worth at least half of the company's latest annual revenue (or, when that's missing, its market cap). An amount this large is often a framework, multi-year or consortium total, not one year of revenue.